Need Help? Call 1­-866-­796-­7386
« back to stock screener

  DRNA stock: Dicerna Pharmaceuticals Inc

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$9.34
Market Cap
260.4M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
-
P/S
189.72
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-51K
FCF
-2.4
Op. Margin
-
Net Margin
-
ROE
-357.70%
ROI
-145.00%
ROA
-106.50%
EPS Growth
-20.40%
Current Ratio
4.8
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
MGC Diagnostics Corp (MGCD) $11.03 - - 48.6M Strong Buy
Digirad Corporation (DRAD) $2.65 - 8.50% 52.7M Strong Buy
Teva Pharmaceutical Industries (TEVA) $21.48 - 4.50% 19.15B Strong Buy
NovaBay Pharmaceuticals, Inc. (NBY) $3.55 - - 55M Strong Buy
American Renal Associates Hold (ARA) $18.60 - - 556.5M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More